These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4710122

  • 1. [Effect of papaveroline on chronic, obliterating, peripheral arterial diseases].
    Sironi G, Benedetti G.
    Minerva Cardioangiol; 1973 Apr; 21(4):257-63. PubMed ID: 4710122
    [No Abstract] [Full Text] [Related]

  • 2. [Physiopathology and therapy of obliterating arteriopathies].
    Schettler G, Mörl H.
    Clin Ter; 1979 Jan 15; 88(1):3-19. PubMed ID: 436376
    [No Abstract] [Full Text] [Related]

  • 3. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK.
    Med Welt; 1973 Sep 28; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract] [Full Text] [Related]

  • 5. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK.
    Munch Med Wochenschr; 1973 Oct 05; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract] [Full Text] [Related]

  • 6. Peripheral arterial disease: drug therapy.
    Schwartz JB.
    J Gend Specif Med; 2002 Oct 05; 5(4):16-20. PubMed ID: 12192882
    [No Abstract] [Full Text] [Related]

  • 7. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G, Tallarida G, Baldoni F, Raimondi G, Grimaldi I, Sangiorgi M.
    Clin Ter; 1985 Jul 15; 114(1):3-26. PubMed ID: 2864161
    [No Abstract] [Full Text] [Related]

  • 8. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 9. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W, Grillo N.
    Minerva Med; 1985 May 12; 76(19-20):945-53. PubMed ID: 3158842
    [Abstract] [Full Text] [Related]

  • 10. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM, Savel'ev IuS.
    Vestn Khir Im I I Grek; 1974 Oct 12; 113(10):68-71. PubMed ID: 4432347
    [No Abstract] [Full Text] [Related]

  • 11. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Oct 12; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 12. [Conservative treatment of peripheral arterial occlusive diseases].
    Hoffmann J.
    Fortschr Med; 1978 Sep 14; 96(34):1735-8. PubMed ID: 101431
    [Abstract] [Full Text] [Related]

  • 13. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A, Russo R, Tomei F, Giordano M, Dragagna G, Barbato G.
    Clin Ter; 1979 Dec 31; 91(6):585-92. PubMed ID: 544162
    [No Abstract] [Full Text] [Related]

  • 14. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):41. PubMed ID: 14974333
    [No Abstract] [Full Text] [Related]

  • 15. [Intra-arterial administration of penicillin and vasodilating agents in occlusive diseases of the peripheral arteries].
    Hubl S, Wesolowski J.
    Pol Tyg Lek; 1973 Jul 23; 28(30):1150-1. PubMed ID: 4732712
    [No Abstract] [Full Text] [Related]

  • 16. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H.
    Fortschr Med; 1980 Feb 21; 98(7):257-60. PubMed ID: 6767648
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC.
    Minerva Med; 1973 May 16; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract] [Full Text] [Related]

  • 18. [Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
    Royer RJ.
    Minerva Med; 1976 May 19; 67(25):1656-61. PubMed ID: 778667
    [No Abstract] [Full Text] [Related]

  • 19. [Piribedil in arterial diseases].
    Cristol R, Arnaud F.
    Nouv Presse Med; 1976 May 19; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.